CHARLOTTESVILLE, VA – Wednesday, January 6, 2010 – Diffusion Pharmaceuticals LLC, a clinical-stage drug-development company commercializing first-in-class drugs to treat serious or life-threatening unmet medical conditions, today announced that David R. Jones, M.D., has joined its staff as Chief Medical Officer and member of its Scientific Advisory Board (SAB). In addition, Guy M. Chisolm, Ph.D., [...]

CHARLOTTESVILLE, VA – April 26, 2007 – Diffusion Pharmaceuticals LLC, a clinical-stage drug discovery and development company pioneering a revolutionary approach to the treatment of life-threatening diseases, today announced that it has formed a Scientific Advisory Board (SAB) to advise the Company on its clinical development programs. The SAB, comprised of four noted scientists and [...]

CHARLOTTESVILLE, VA – November 7, 2006 – Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary approach to treat life-threatening diseases, today announced that it has appointed Matthew W. Hantzmon to the new position of Vice President, Business Development. Mr. Hantzmon, a senior executive with a successful record in medical technology and [...]

CHARLOTTESVILLE, VA — June 6, 2006 — Diffusion Pharmaceuticals LLC, a drug discovery and development company, today announced that VaBIO, a membership organization that promotes the scientific and economic impact of the life sciences industry in the Commonwealth of Virginia, awarded it for the third year a $1,500 grant as part of the organization’s Summer [...]

Charlottesville, VA — July 1, 2005 — Diffusion Pharmaceuticals LLC, a drug discovery and development company pioneering a revolutionary mechanism of action to treat life-threatening diseases, today announced the completion of its laboratory and research capabilities expansion. Since June, the company has added three people to oversee activities in its laboratories: Dr. John Gainer, company [...]